ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

ASND Ascendis Pharma AS

140.15
0.00 (0.00%)
30 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Ascendis Pharma AS ASND 나스닥 주식예탁증서 (DR)
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 140.15 09:00:00
개장가 저가 고가 종가 전일 종가
140.15
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
26/04/202405:46GLOBEAscendis Pharma to Report First Quarter 2024 Financial..
24/04/202421:30GLOBEUnited Kingdom’s MHRA Approves YORVIPATH®..
08/03/202401:31EDGAR2Form 144 - Report of proposed sale of securities
06/03/202411:39EDGAR2Form 144 - Report of proposed sale of securities
05/03/202422:14EDGAR2Form 144 - Report of proposed sale of securities
05/03/202422:04EDGAR2Form 144 - Report of proposed sale of securities
05/03/202421:37EDGAR2Form 144 - Report of proposed sale of securities
05/03/202405:17EDGAR2Form 144 - Report of proposed sale of securities
05/03/202405:07EDGAR2Form 144 - Report of proposed sale of securities
05/03/202404:54EDGAR2Form 144 - Report of proposed sale of securities
05/03/202404:36EDGAR2Form 144 - Report of proposed sale of securities
04/03/202422:30GLOBEAscendis Pharma to Participate in the Leerink Partners..
02/03/202401:00EDGAR2Form 144 - Report of proposed sale of securities
01/03/202407:13EDGAR2Form 144 - Report of proposed sale of securities
29/02/202406:49EDGAR2Form 144 - Report of proposed sale of securities
28/02/202407:45EDGAR2Form 144 - Report of proposed sale of securities
22/02/202405:17EDGAR2Form 144 - Report of proposed sale of securities
17/02/202407:16EDGAR2Form 144 - Report of proposed sale of securities
17/02/202407:15EDGAR2Form 144 - Report of proposed sale of securities
17/02/202407:14EDGAR2Form 144 - Report of proposed sale of securities
15/02/202406:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/02/202401:40EDGAR2Form 144 - Report of proposed sale of securities
14/02/202423:17EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/02/202406:15EDGAR2Form 20-F - Annual and transition report of foreign private..
08/02/202406:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/02/202406:01GLOBEAscendis Pharma Reports Fourth Quarter and Full Year 2023..
07/02/202422:30GLOBEAscendis Pharma to Participate in the Oppenheimer 34th..
01/02/202406:15GLOBEAscendis Pharma to Report Full Year 2023 Financial Results..
01/02/202406:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/02/202406:01GLOBEAscendis Pharma Launches 2nd TransCon™ Product: YORVIPATH®..
29/01/202422:36EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/01/202422:30GLOBENew Company Eyconis Formed to Develop Ascendis Pharma..
11/01/202406:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/01/202422:20GLOBEVector Pharma FZCO Announce Exclusive Distribution Agreement..
08/01/202420:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/01/202420:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/01/202407:45GLOBEAscendis Pharma Introduces Vision 2030
08/01/202404:00PRNUSSpecialised Therapeutics signs exclusive agreement with..
02/01/202420:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/12/202306:15GLOBEAscendis Pharma to Participate in the 42nd Annual J.P...
20/12/202322:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/12/202322:30GLOBESignificant Health and Quality of Life Improvements Achieved..
20/12/202306:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/12/202322:30GLOBETransCon™ hGH (lonapegsomatropin) Achieved Statistically..
14/12/202306:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/12/202322:32EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/12/202322:30GLOBEFDA Accepts for Review Resubmitted NDA for TransCon PTH..
08/12/202304:53EDGAR2Form 144 - Report of proposed sale of securities
06/12/202306:20EDGAR2Form 144 - Report of proposed sale of securities
01/12/202305:44EDGAR2Form 144 - Report of proposed sale of securities

최근 히스토리

Delayed Upgrade Clock